445 related articles for article (PubMed ID: 29364519)
21. Purification of Pluripotent Stem Cell-Derived Cardiomyocytes Using CRISPR/Cas9-Mediated Integration of Fluorescent Reporters.
Galdos FX; Darsha AK; Paige SL; Wu SM
Methods Mol Biol; 2021; 2158():223-240. PubMed ID: 32857377
[TBL] [Abstract][Full Text] [Related]
22. [Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].
Liu GG; Li S; Wei YD; Zhang YX; Ding QR
Yi Chuan; 2015 Nov; 37(11):1167-73. PubMed ID: 26582531
[TBL] [Abstract][Full Text] [Related]
23. Efficient bi-allelic tagging in human induced pluripotent stem cells using CRISPR.
Ren X; Takagi MA; Shen Y
STAR Protoc; 2023 Mar; 4(1):102084. PubMed ID: 36853689
[TBL] [Abstract][Full Text] [Related]
24. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
[TBL] [Abstract][Full Text] [Related]
25. Genome editing of hPSCs: Recent progress in hPSC-based disease modeling for understanding disease mechanisms.
Choi DK; Kim YK; HoonYu J; Min SH; Park SW
Prog Mol Biol Transl Sci; 2021; 181():271-287. PubMed ID: 34127196
[TBL] [Abstract][Full Text] [Related]
26. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
27. Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation.
Xu X; Gao D; Wang P; Chen J; Ruan J; Xu J; Xia X
Sci Rep; 2018 Aug; 8(1):11649. PubMed ID: 30076383
[TBL] [Abstract][Full Text] [Related]
28. Human induced pluripotent stem cells and CRISPR/Cas-mediated targeted genome editing: Platforms to tackle sensorineural hearing loss.
Stojkovic M; Han D; Jeong M; Stojkovic P; Stankovic KM
Stem Cells; 2021 Jun; 39(6):673-696. PubMed ID: 33586253
[TBL] [Abstract][Full Text] [Related]
29. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
30. CRISPR/Cas9-Directed Genome Editing of Cultured Cells.
Yang L; Yang JL; Byrne S; Pan J; Church GM
Curr Protoc Mol Biol; 2014 Jul; 107():31.1.1-31.1.17. PubMed ID: 24984853
[TBL] [Abstract][Full Text] [Related]
31. Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery.
De Masi C; Spitalieri P; Murdocca M; Novelli G; Sangiuolo F
Hum Genomics; 2020 Jun; 14(1):25. PubMed ID: 32591003
[TBL] [Abstract][Full Text] [Related]
32. Potential pitfalls of CRISPR/Cas9-mediated genome editing.
Peng R; Lin G; Li J
FEBS J; 2016 Apr; 283(7):1218-31. PubMed ID: 26535798
[TBL] [Abstract][Full Text] [Related]
33. Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR-Cas9 genome editing.
Paulsen BS; Mandal PK; Frock RL; Boyraz B; Yadav R; Upadhyayula S; Gutierrez-Martinez P; Ebina W; Fasth A; Kirchhausen T; Talkowski ME; Agarwal S; Alt FW; Rossi DJ
Nat Biomed Eng; 2017 Nov; 1(11):878-888. PubMed ID: 31015609
[TBL] [Abstract][Full Text] [Related]
34. Conversion Tract Analysis of Homology-Directed Genome Editing Using Oligonucleotide Donors.
Kan Y; Hendrickson EA
Methods Mol Biol; 2019; 1999():131-144. PubMed ID: 31127573
[TBL] [Abstract][Full Text] [Related]
35. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
[TBL] [Abstract][Full Text] [Related]
36. Editing the Genome of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes.
Bruntraeger M; Byrne M; Long K; Bassett AR
Methods Mol Biol; 2019; 1961():153-183. PubMed ID: 30912046
[TBL] [Abstract][Full Text] [Related]
37. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
38. Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing.
Miyaoka Y; Berman JR; Cooper SB; Mayerl SJ; Chan AH; Zhang B; Karlin-Neumann GA; Conklin BR
Sci Rep; 2016 Mar; 6():23549. PubMed ID: 27030102
[TBL] [Abstract][Full Text] [Related]
39. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
40. Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides.
Dong Y; Peng T; Wu W; Tan D; Liu X; Xie D
J Int Med Res; 2019 Apr; 47(4):1717-1730. PubMed ID: 30819013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
